Yuping Du

1.6k total citations · 1 hit paper
36 papers, 1.2k citations indexed

About

Yuping Du is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yuping Du has authored 36 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 13 papers in Cancer Research and 12 papers in Oncology. Recurrent topics in Yuping Du's work include Cytokine Signaling Pathways and Interactions (9 papers), PI3K/AKT/mTOR signaling in cancer (7 papers) and Circular RNAs in diseases (7 papers). Yuping Du is often cited by papers focused on Cytokine Signaling Pathways and Interactions (9 papers), PI3K/AKT/mTOR signaling in cancer (7 papers) and Circular RNAs in diseases (7 papers). Yuping Du collaborates with scholars based in China, United States and United Kingdom. Yuping Du's co-authors include Yang Zhao, Shuo Chen, Zhi‐Hong Zong, Zhenghao Huang, Xue Guan, Jinbo Yang, Nan Jing, Xing Chen, George R. Stark and Nathaniel C. Sears and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Water Research.

In The Last Decade

Yuping Du

35 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lactate accumulation induces H4K12la to activate super-enhancer-driven RAD23A expression and promote niraparib resistance in ovarian cancer

2025 18 citations Shuo Chen, Xue Guan et al. Molecular Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yuping Du China	19	843	443	261	160	68	36	1.2k
Elham Baghbani Iran	19	756 0.9×	487 1.1×	275 1.1×	190 1.2×	104 1.5×	55	1.2k
Saeid Abroun Iran	20	684 0.8×	210 0.5×	368 1.4×	227 1.4×	76 1.1×	72	1.2k
Evangelos Kolettas Greece	22	760 0.9×	383 0.9×	309 1.2×	149 0.9×	59 0.9×	51	1.4k
Hongyan Jin China	20	879 1.0×	557 1.3×	219 0.8×	111 0.7×	59 0.9×	32	1.3k
Peishu Liu China	22	774 0.9×	473 1.1×	169 0.6×	131 0.8×	90 1.3×	62	1.2k
Yi Xiao China	19	668 0.8×	344 0.8×	316 1.2×	79 0.5×	52 0.8×	71	1.1k
Suryavathi Viswanadhapalli United States	19	869 1.0×	361 0.8×	203 0.8×	145 0.9×	50 0.7×	62	1.4k
Neda Shajari Iran	10	616 0.7×	255 0.6×	148 0.6×	85 0.5×	89 1.3×	14	833
Saeed Noorolyai Iran	11	451 0.5×	225 0.5×	171 0.7×	102 0.6×	70 1.0×	24	708

Countries citing papers authored by Yuping Du

Since Specialization

Citations

This map shows the geographic impact of Yuping Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuping Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuping Du more than expected).

Fields of papers citing papers by Yuping Du

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuping Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuping Du. The network helps show where Yuping Du may publish in the future.

Co-authorship network of co-authors of Yuping Du

This figure shows the co-authorship network connecting the top 25 collaborators of Yuping Du. A scholar is included among the top collaborators of Yuping Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuping Du. Yuping Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Baixue, et al.. (2025). Super-enhancers in tumors: unraveling recent advances in their role in Oncogenesis and the emergence of targeted therapies. Journal of Translational Medicine. 23(1). 98–98. 4 indexed citations

Han, Yang, Jianqi Li, Qinghua Wu, et al.. (2025). piRNA28846 has the potential to be a novel RNA nucleic acid drug for ovarian cancer. npj Precision Oncology. 9(1). 65–65. 1 indexed citations

Chen, Shuo, Xue Guan, Xi Chen, et al.. (2025). Lactate accumulation induces H4K12la to activate super-enhancer-driven RAD23A expression and promote niraparib resistance in ovarian cancer. Molecular Cancer. 24(1). 83–83. 18 indexed citations breakdown →

Du, Yuping, Siyu Chen, Xiaomin Hu, et al.. (2024). Understanding visible light and microbe-driven degradation mechanisms of polyurethane plastics: Pathways, property changes, and product analysis. Water Research. 259. 121856–121856. 45 indexed citations

Huang, Zhenghao, et al.. (2022). snoRNAs: functions and mechanisms in biological processes, and roles in tumor pathophysiology. Cell Death Discovery. 8(1). 259–259. 117 indexed citations

Chen, Shuo, Wu Wu, Yuping Du, et al.. (2021). Circ-NOLC1 promotes epithelial ovarian cancer tumorigenesis and progression by binding ESRP1 and modulating CDK1 and RhoA expression. Cell Death Discovery. 7(1). 22–22. 36 indexed citations

Zhao, Cheng, et al.. (2021). circRNA circFAT1(e2) Elevates the Development of Non‐Small‐Cell Lung Cancer by Regulating miR‐30e‐5p and USP22. BioMed Research International. 2021(1). 6653387–6653387. 8 indexed citations

Du, Yuping, Xin Liu, Shuo Chen, et al.. (2021). CircCRIM1 promotes ovarian cancer progression by working as ceRNAs of CRIM1 and targeting miR-383-5p/ZEB2 axis. Reproductive Biology and Endocrinology. 19(1). 176–176. 24 indexed citations

Du, Yuping, Xinxin Zhang, Zhuoya Wang, et al.. (2019). Discovery and evaluation of Atopaxar hydrobromide, a novel JAK1 and JAK2 inhibitor, selectively induces apoptosis of cancer cells with constitutively activated STAT3. Investigational New Drugs. 38(4). 1003–1011. 6 indexed citations

10.

Liu, Yao, Shuo Chen, Zhi‐Hong Zong, et al.. (2019). circ-CSPP1 promotes proliferation, invasion and migration of ovarian cancer cells by acting as a miR-1236-3p sponge. Biomedicine & Pharmacotherapy. 114. 108832–108832. 60 indexed citations

11.

Zong, Zhi‐Hong, Yuping Du, Xue Guan, Shuo Chen, & Yang Zhao. (2019). CircWHSC1 promotes ovarian cancer progression by regulating MUC1 and hTERT through sponging miR-145 and miR-1182. Journal of Experimental & Clinical Cancer Research. 38(1). 437–437. 111 indexed citations

12.

Du, Yuping, Qiaoling Song, Nan Jing, et al.. (2018). E2F is required for STAT3-mediated upregulation of cyclin B1 and Cdc2 expressions and contributes to G2–M phase transition. Acta Biochimica et Biophysica Sinica. 51(3). 313–322. 31 indexed citations

13.

Zhu, Ning, et al.. (2016). ZIP restores estrogen receptor expression and response to Tamoxifen in estrogen receptor negative tumors. Biochemical and Biophysical Research Communications. 480(4). 570–573. 1 indexed citations

14.

Zhang, Jing, Ning Zhu, Yuping Du, et al.. (2015). Dehydrocrenatidine Is a Novel Janus Kinase Inhibitor. Molecular Pharmacology. 87(4). 572–581. 10 indexed citations

15.

Jing, Nan, Yuping Du, Xing Chen, et al.. (2014). TPCA-1 Is a Direct Dual Inhibitor of STAT3 and NF-κB and Regresses Mutant EGFR-Associated Human Non–Small Cell Lung Cancers. Molecular Cancer Therapeutics. 13(3). 617–629. 78 indexed citations

16.

Du, Yuping, et al.. (2014). Activation of Akt protects cancer cells from growth inhibition induced by PKM2 knockdown. Cell & Bioscience. 4(1). 20–20. 15 indexed citations

17.

Chen, Xing, Yuping Du, Nan Jing, et al.. (2013). Brevilin A, a Novel Natural Product, Inhibits Janus Kinase Activity and Blocks STAT3 Signaling in Cancer Cells. PLoS ONE. 8(5). e63697–e63697. 59 indexed citations

18.

Shi, Jie, Ximing Xu, Wenhua Zhang, et al.. (2012). STAT3 mutations correlated with hyper-IgE syndrome lead to blockage of IL-6/STAT3 signalling pathway. Journal of Biosciences. 37(2). 243–257. 25 indexed citations

19.

Bai, Qifeng, Xiaojun Yao, Fang Wang, et al.. (2011). Modeling a New Water Channel That Allows SET9 to Dimethylate p53. PLoS ONE. 6(5). e19856–e19856. 14 indexed citations

20.

Miao, Ruidong, Juan Wei, Yan Cai, et al.. (2011). Conjugation of substituted ferrocenyl to thiadiazine as apoptosis-inducing agents targeting the Bax/Bcl-2 pathway. European Journal of Medicinal Chemistry. 46(10). 5000–5009. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact